المؤلفون: Aly, M, Hashim, M, Heeg, B, Liwing, J, Leval, A, Mehra, M, Lawson, J, Brookman-May, SD, Akre, O

المصدر: European urology focus. 5(5):788-798

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:142074154

المؤلفون: Capitanio, U, Stewart, GD, Larcher, A, Ouzaid, I, Akdogan, B, Roscigno, M, Marszalek, M, Dell'Oglio, P, Salagierski, M, Volpe, A, Mir, MC, Kriegmair, M, Terrone, C, Brookman-May, SD, Montorsi, F, Klatte, T, Kidney Cancer Working Group of the Young Academic Urologists (YAU) Working Party of the European Association of Urology (EAU)

المساهمون: Stewart, Grant [0000-0003-3188-9140], Apollo - University of Cambridge Repository

مصطلحات موضوعية: Renal cancer, Kidney cancer, Lymphadenectomy, Lymph node dissection, Nephrectomy

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f584704f198d91aab9a3d250ac4fb96e

المؤلفون: Faba, OR, Brookman-May, SD, Linares, E, Breda, A, Pisano, F, Subiela, JD, Sanguedolce, F, Brausi, M, Palou, J

المصدر: WORLD JOURNAL OF UROLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Universidad Europea (UEM)

مصطلحات موضوعية: Targeted therapy, Renal cancer, Cytoreductive nephrectomy, Metastatic

URL الوصول: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::77a18d7a6ab9bc159dea784283188334
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=5977

المؤلفون: Brookman-May, SD, Sterzik, A, Solyanik, O, Graser, A, Jost, M, Lausenmeyer, EM, Otto, W, Burger, M, Reiser, M, Stief, CG, May, M

المصدر: 43. Gemeinsame Tagung der Österreichischen Gesellschaft für Urologie und Andrologie und der Bayerischen Urologenvereinigung; 20170518-20170520; Wien; DOC17oegu028 /20170403/

مصطلحات الفهرس: ddc: 610, conferenceObject

URL: http://nbn-resolving.de/urn:nbn:de:0183-17oegu0288
http://www.egms.de/en/meetings/oegu2017/17oegu028.shtml

المؤلفون: Brookman-May, SD, May, M, Wolff, I, Zigeuner, R, Hutterer, GC, Cindolo, L, Schips, L, Truss, M, Dalpiaz, O, Zastrow, S, Wirth, M, Shariat, SF, Waidelich, R, Stief, CG, Gunia, S

المصدر: 41. Gemeinsame Tagung der Österreichischen Gesellschaft für Urologie und Andrologie und der Bayerischen Urologenvereinigung; 20150611-20150613; Linz; DOCKV10 /20150519/

مصطلحات الفهرس: ddc: 610, conferenceObject

URL: http://nbn-resolving.de/urn:nbn:de:0183-15oegu242
http://www.egms.de/en/meetings/oegu2015/15oegu24.shtml

المؤلفون: Brookman May SD, May, M, Shariat, Sf, Novara, G, Zigeuner, R, Cindolo, L, De Cobelli, O, De Nunzio, C, Pahernik, S, Wirth, Mp, Longo, N, Simonato, A, Serni, S, Siracusano, S, Volpe, A, Morgia, Giuseppe Maria, Bertini, R, Dalpiaz, O, Stief, C, Ficarra, V, Members of the CORONA Project, Members of the SATURN Project, Young Academic Urologists Renal Cancer Group

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______4731::92b0fe3b7ee86cff848f14ce70890276
http://hdl.handle.net/20.500.11769/56517

المؤلفون: Karsh LI; The Urology Center of Colorado, Denver, CO, USA., Bevans KB; Janssen Global Commercial Strategy Organization, Horsham, PA, USA., Saad F; Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada., Chung BH; Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea., Oudard S; Georges Pompidou Hospital, Université Paris Cité, Paris, France., Brookman-May SD; Ludwig-Maximilians-University, Munich, Germany.; Janssen Research & Development, Spring House, PA, USA., McCarthy SA; Janssen Research & Development, Raritan, NJ, USA., Smith MR; Massachusetts General Hospital Cancer Center & Harvard Medical School, Boston, MA, USA., Chi KN; BC Cancer & Vancouver Prostate Centre, Vancouver, BC, Canada., Small EJ; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA., Agarwal N; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.

المصدر: Future oncology (London, England) [Future Oncol] 2024 Aug 20, pp. 1-10. Date of Electronic Publication: 2024 Aug 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: MEDLINE

المؤلفون: Brookman-May SD; Department of Urology, LMU University Hospital, LMU Munich, Munich, Germany. Electronic address: sabine.brookman-may@email.de., Kamat AM; Department of Urology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., May M; Department of Urology, St. Elisabeth Hospital Straubing, Brothers of Mercy Hospital, Straubing, Germany.

المصدر: European urology [Eur Urol] 2024 Aug 19. Date of Electronic Publication: 2024 Aug 19.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE

المؤلفون: Honma Y; Department of Head and Neck, Esophageal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan., Monden N; Department of Head and Neck, Surgery, National Hospital Organization Shikoku Cancer Center, Ehime, Japan., Yamazaki K; Department of Otolaryngology-Head and Neck Surgery, Graduate School of Medical, and Dental Sciences, Niigata University, Niigata, Japan., Kano S; Department of Otolaryngology-Head and Neck Surgery, Faculty of Medicine, Graduate School of Medicine, Hokkaido University, Hokkaido, Japan., Satake H; Cancer Treatment Center, Kansai Medical University Hospital, Osaka & Department of Medical Oncology, Kochi Medical School, Kochi, Japan., Kadowaki S; Department of Clinical Oncology, Aichi Cancer Center Hospital, Aichi, Japan., Utsumi Y; Department of Anatomic Pathology, Tokyo Medical University, Tokyo, Japan., Nakatogawa T; Janssen Pharmaceutical K.K., Tokyo, Japan., Takano R; Janssen Pharmaceutical K.K., Tokyo, Japan., Fujii K; Janssen Pharmaceutical K.K., Tokyo, Japan., Koroki Y; Janssen Pharmaceutical K.K., Tokyo, Japan., Aoyama J; Janssen Pharmaceutical K.K., Tokyo, Japan., Ouchi S; Janssen Pharmaceutical K.K., Tokyo, Japan., Ogawa T; Janssen Pharmaceutical K.K., Tokyo, Japan., McCarthy S; Janssen Research & Development, Spring House, Pennsylvania, USA., Brookman-May SD; Janssen Research & Development, Spring House, Pennsylvania, USA.; Ludwig-Maximilians University (LMU), Munich, Germany., Mundle S; Janssen Research & Development, Spring House, Pennsylvania, USA., Li J; Janssen Research & Development, Spring House, Pennsylvania, USA., Thaper D; Janssen Research & Development, Spring House, Pennsylvania, USA., Nagao T; Department of Anatomic Pathology, Tokyo Medical University, Tokyo, Japan., Tada Y; Department of Head and Neck Oncology and Surgery, International University of Health and Welfare, Mita Hospital, Tokyo, Japan.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Aug 15; Vol. 30 (16), pp. 3416-3427.

نوع المنشور: Journal Article; Clinical Trial, Phase II; Multicenter Study

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Salivary Gland Neoplasms*/drug therapy , Salivary Gland Neoplasms*/pathology , Salivary Gland Neoplasms*/metabolism , Salivary Gland Neoplasms*/mortality , Receptors, Androgen*/metabolism , Thiohydantoins*/administration & dosage , Thiohydantoins*/therapeutic use , Thiohydantoins*/adverse effects , Goserelin*/administration & dosage , Goserelin*/therapeutic use , Goserelin*/adverse effects, Humans ; Male ; Middle Aged ; Female ; Aged ; Adult ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Aged, 80 and over ; Treatment Outcome ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/pathology

المؤلفون: Small EJ; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. Electronic address: eric.small@ucsf.edu., Chi KN; BC Cancer and Vancouver Prostate Centre, Vancouver, BC, Canada., Chowdhury S; Guy's, King's, and St. Thomas' Hospitals and Sarah Cannon Research Institute, London, UK., Bevans KB; Janssen Global Commercial Strategy Organization, Horsham, PA, USA., Bhaumik A; Janssen Research & Development, Titusville, NJ, USA., Saad F; Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada., Chung BH; Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea., Karsh LI; The Urology Center of Colorado, Denver, CO, USA., Oudard S; Georges Pompidou Hospital, Université Paris Descartes, Paris, France., De Porre P; Janssen Research & Development, Beerse, Belgium., Brookman-May SD; Ludwig-Maximilians-University, Munich, Germany; Janssen Research & Development, Spring House, PA, USA., McCarthy SA; Janssen Research & Development, Raritan, NJ, USA., Mundle SD; Janssen Research & Development, Raritan, NJ, USA., Uemura H; Kindai University Faculty of Medicine, Osaka, Japan., Smith MR; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, USA., Agarwal N; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.

المصدر: European urology oncology [Eur Urol Oncol] 2024 Aug; Vol. 7 (4), pp. 844-852. Date of Electronic Publication: 2023 Dec 09.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Quality of Life* , Prostate-Specific Antigen*/blood , Thiohydantoins*/therapeutic use , Patient Reported Outcome Measures* , Androgen Antagonists*/therapeutic use, Humans ; Male ; Aged ; Prostatic Neoplasms, Castration-Resistant/drug therapy ; Prostatic Neoplasms, Castration-Resistant/pathology ; Middle Aged ; Prostatic Neoplasms/drug therapy ; Prostatic Neoplasms/pathology ; Prostatic Neoplasms/blood ; Disease Progression